Fda approves colosense™ – geneoscopy's noninvasive multi-target stool rna (mt-srna) colorectal cancer screening test

St. louis--(business wire)--geneoscopy, inc. announced that the u.s. food and drug administration (fda) approved its noninvasive colorectal cancer screening test, colosense.

LH Ratings Summary

LH Quant Ranking